CINECA IRIS Institutional Research Information System

PALERMO, GIOVANNI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.824
AS - Asia 1.844
EU - Europa 1.346
SA - Sud America 300
AF - Africa 106
OC - Oceania 21
Totale 6.441
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.744
SG - Singapore 622
CN - Cina 499
IT - Italia 396
HK - Hong Kong 377
BR - Brasile 250
DE - Germania 221
SE - Svezia 199
VN - Vietnam 99
AT - Austria 86
GB - Regno Unito 79
BG - Bulgaria 67
FI - Finlandia 64
FR - Francia 50
RU - Federazione Russa 49
IN - India 47
KR - Corea 46
CI - Costa d'Avorio 43
CA - Canada 35
PL - Polonia 33
TR - Turchia 32
NL - Olanda 31
MX - Messico 24
AR - Argentina 21
AU - Australia 21
JP - Giappone 21
ES - Italia 20
SN - Senegal 16
IQ - Iraq 15
MA - Marocco 13
BD - Bangladesh 12
IE - Irlanda 11
PK - Pakistan 11
UA - Ucraina 10
UZ - Uzbekistan 10
ID - Indonesia 9
PE - Perù 9
ZA - Sudafrica 9
KE - Kenya 7
AE - Emirati Arabi Uniti 6
EG - Egitto 6
LT - Lituania 6
PA - Panama 6
SA - Arabia Saudita 6
CZ - Repubblica Ceca 5
EC - Ecuador 5
IL - Israele 5
NG - Nigeria 5
PH - Filippine 5
PY - Paraguay 5
MY - Malesia 4
TW - Taiwan 4
BE - Belgio 3
CR - Costa Rica 3
DZ - Algeria 3
GR - Grecia 3
NP - Nepal 3
UY - Uruguay 3
AZ - Azerbaigian 2
BB - Barbados 2
CL - Cile 2
CO - Colombia 2
HN - Honduras 2
HU - Ungheria 2
JM - Giamaica 2
KG - Kirghizistan 2
LU - Lussemburgo 2
VE - Venezuela 2
AO - Angola 1
BO - Bolivia 1
BS - Bahamas 1
CH - Svizzera 1
CY - Cipro 1
DK - Danimarca 1
DM - Dominica 1
DO - Repubblica Dominicana 1
EE - Estonia 1
ET - Etiopia 1
GD - Grenada 1
GE - Georgia 1
IM - Isola di Man 1
IS - Islanda 1
JO - Giordania 1
KZ - Kazakistan 1
LB - Libano 1
LK - Sri Lanka 1
LV - Lettonia 1
MN - Mongolia 1
NO - Norvegia 1
PT - Portogallo 1
RS - Serbia 1
SV - El Salvador 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
YT - Mayotte 1
Totale 6.441
Salva come PNG Salva come JPEG
Città #
Dallas 464
Ashburn 389
Hong Kong 376
Singapore 346
Santa Clara 230
Fairfield 174
Chandler 165
Shanghai 135
Woodbridge 115
Munich 102
New York 100
Milan 89
Boardman 83
Seattle 82
Beijing 80
Houston 79
Vienna 77
Wilmington 74
Hefei 71
Los Angeles 71
Frankfurt am Main 67
Sofia 67
Cambridge 46
Seoul 46
Turku 45
Abidjan 43
Florence 41
Princeton 41
Pisa 38
Lawrence 35
Serra 29
Medford 28
Warsaw 28
Ho Chi Minh City 26
Ann Arbor 25
Guangzhou 24
São Paulo 24
London 23
Lucca 21
Redondo Beach 21
Buffalo 18
Tokyo 18
Bremen 17
Istanbul 17
Melbourne 17
Rome 17
Trieste 17
Dakar 16
Mexico City 15
Ogden 14
San Diego 13
Fuzhou 11
Hanoi 11
Helsinki 11
Boulder 10
Chennai 10
Paris 10
La Spezia 9
Nuremberg 9
San Francisco 9
Stockholm 9
Baghdad 8
Casablanca 8
Dong Ket 8
Manchester 8
Montignoso 8
Montreal 8
Tashkent 8
Toronto 8
Belo Horizonte 7
Brooklyn 7
Denver 7
Haiphong 7
Newcastle upon Tyne 7
Ottawa 7
Phoenix 7
Rio de Janeiro 7
Amsterdam 6
Barcelona 6
Boston 6
Chicago 6
Des Moines 6
Naples 6
Orem 6
Palaia 6
Atlanta 5
Brno 5
Cascina 5
Dublin 5
Düsseldorf 5
Hyderabad 5
Johannesburg 5
Lagos 5
Lappeenranta 5
Lauterbourg 5
Panama City 5
Poplar 5
Portsmouth 5
Rivne 5
São Bernardo do Campo 5
Totale 4.541
Salva come PNG Salva come JPEG
Nome #
Clinical Correlates of Cerebral Amyloid Deposition in Parkinson's Disease Dementia: Evidence from a PET Study 257
Brain-Derived Neurotrophic Factor (BDNF) and Serotonin Transporter (SERT) in Platelets of Patients with Mild Huntington’s Disease: Relationships with Social Cognition Symptoms 218
α-Synuclein Heteromers in Red Blood Cells of Alzheimer's Disease and Lewy Body Dementia Patients 182
Antipsychotic drugs in Huntington's disease 176
Different Clinical Contexts of Use of Blood Neurofilament Light Chain Protein in the Spectrum of Neurodegenerative Diseases 150
Intestinal histomorphological and molecular alterations in patients with Parkinson's disease 143
Dissecting the Interplay between Time of Dementia and Cognitive Profiles in Lewy Body Dementias 137
The neuroinflammatory biomarker YKL-40 for neurodegenerative diseases: advances in development 136
A frontline defense against neurodegenerative diseases:the development of early disease detection methods 135
Prevalence and clinical correlates of comorbid anxiety and panic disorders in patients with Parkinson’s disease 135
Impact of COVID-19 pandemic on cognition in Parkinson's disease 133
Connected speech in progressive supranuclear palsy: a possible role in differential diagnosis 133
Levodopa and neuropathy risk in patients with Parkinson disease: Effect of COMT inhibition 129
Advances in the pharmacotherapeutic management of dementia with Lewy bodies 128
Brain Aβ load association and sexual dimorphism of plasma BACE1 concentrations in cognitively normal individuals at risk for AD 128
Prevalence and impact of COVID-19 in Parkinson’s disease: evidence from a multi-center survey in Tuscany region 128
Freezing of gait and dementia in parkinsonism: A retrospective case–control study 125
A Path Toward Precision Medicine for Neuroinflammatory Mechanisms in Alzheimer's Disease 124
Fluid Biomarkers in Alzheimer’s Disease and Other Neurodegenerative Disorders: Toward Integrative Diagnostic Frameworks and Tailored Treatments 120
Differential default mode network trajectories in asymptomatic individuals at risk for Alzheimer's disease 119
MiRNA-15b and miRNA-125b are associated with regional Aβ-PET and FDG-PET uptake in cognitively normal individuals with subjective memory complaints 117
Progress regarding the context-of-use of tau as biomarker of Alzheimer's disease and other neurodegenerative diseases 115
Involvement of the Nigrostriatal Pathway in Patients With Idiopathic Normal Pressure Hydrocephalus and Parkinsonism 112
Exploring the Distinct Effect of Age at Onset and Caudate Denervation on Cognitive Deficits in Early Parkinson's Disease 107
Extended release levodopa at bedtime as a treatment for nocturiain Parkinson's disease: An open label study 107
Botulinum toxin for the treatment of dystonia and pain in corticobasal syndrome 106
Theory of mind in Parkinson’s disease: evidences in drug-naïve patients and longitudinal effects of dopaminergic therapy 106
Negative DAT-SPECT in Old Onset Parkinson's Disease: An Additional Pitfall? 105
Dopamine Transporter, Age, and Motor Complications in Parkinson's Disease: A Clinical and Single-Photon Emission Computed Tomography Study 104
Understanding the Multiple Role of Mitochondria in Parkinson’s Disease and Related Disorders: Lesson From Genetics and Protein–Interaction Network 104
β-Secretase1 biological markers for Alzheimer’s disease: state-of-art of validation and qualification 104
Age and sex impact plasma NFL and t-Tau trajectories in individuals with subjective memory complaints: a 3-year follow-up study 103
Neurogenic orthostatic hypotension in Parkinson's disease: is there a role for locus coeruleus magnetic resonance imaging? 101
Future avenues for Alzheimer's disease detection and therapy: Liquid biopsy, intracellular signaling modulation, systems pharmacology drug discovery 97
Understanding the Multiple Role of Mitochondria in Parkinson’s Disease and Related Disorders: Lesson From Genetics and Protein–Interaction Network 95
Dopamine transporter imaging, current status of a potential biomarker: A comprehensive review 94
Qualitative evaluation of the Rey-Osterrieth Complex Figure Test in patients with progressive supranuclear palsy 93
Statins in Parkinson's Disease: Influence on Motor Progression 86
Mitochondrial Parkinsonism: A Practical Guide to Genes and Clinical Diagnosis 86
Two cases of Huntington's disease unmasked by the COVID-19 pandemic 86
The role of synaptic biomarkers in the spectrum of neurodegenerative diseases 86
null 86
Diagnosis of hereditary ataxias: a real-world single center experience 84
Supplementing Best Care with Specialized Rehabilitation Treatment in Parkinson’s Disease: A Retrospective Study by Different Expert Centers 83
Aptamarker prediction of brain amyloid-β status in cognitively normal individuals at risk for Alzheimer’s disease 82
Different Patterns of Locus Coeruleus MRI Alteration in Alzheimer’s and Dementia with Lewy Bodies 81
Molecular Imaging of the Dopamine Transporter 80
Prokineticin-2 Is Highly Expressed in Colonic Mucosa of Early Parkinson's Disease Patients 79
Early autonomic and cognitive dysfunction in PD, DLB and MSA: blurring the boundaries between α-synucleinopathies 77
Association of plasma YKL-40 with brain amyloid-β levels, memory performance, and sex in subjective memory complainers 74
Early Compensatory Mechanisms in LRRK2 Mutation Carriers 73
Expanding Glucocerebrosidase Involvement in Neurodegeneration: D419H Mutation Causing Dementia with Lewy Bodies 73
Dominant VPS16 Pathogenic Variants: Not Only Isolated Dystonia 72
Family History in Parkinson's Disease: A National Cross-Sectional Study 71
Benign versus malignant Parkinson disease: the unexpected silver lining of motor complications 71
Perampanel as a novel treatment for subcortical myoclonus in myoclonus-dystonia syndrome 69
Mild Cognitive Impairment in de novo Parkinson's Disease: Selective Attention Deficit as Early Sign of Neurocognitive Decay 64
α-Synuclein in Parkinson's Disease: From Bench to Bedside 60
SLC25A46 mutations in patients with Parkinson's Disease and optic atrophy 55
Blood-based systems biology biomarkers for next-generation clinical trials in Alzheimer’s disease 54
Essential tremor and cognitive impairment: who, how, and why 41
Tardive Syndrome Associated With Tetrabenazine in Huntington Disease: A Case Report 40
Clues to Reshaping Anti-α-Synuclein Immunotherapy in Early Parkinson's Disease Patients 34
Biomarker-drug and liquid biopsy co-development for disease staging and targeted therapy: Cornerstones for Alzheimer’s precision medicine and pharmacology 18
Commentary: Development of the Blood-Based Alzheimer's Disease Liquid Biopsy 15
Totale 6.586
Salva come PNG Salva come JPEG
Categoria #
all - tutte 21.575
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.575
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021221 0 0 0 0 0 24 57 14 46 10 25 45
2021/2022350 8 7 5 13 59 47 12 14 30 22 28 105
2022/2023695 84 108 71 46 55 67 6 41 151 1 53 12
2023/2024564 45 49 46 32 75 140 30 12 5 9 50 71
2024/20252.297 23 71 53 113 161 208 186 104 258 334 327 459
2025/20261.853 232 376 466 323 294 162 0 0 0 0 0 0
Totale 6.586